帕金森病与纹状体多巴胺：人脑中存在多巴胺的体内形态学证据 - Suppr

Suppr

超能文献

Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.

作者信息

Constantinidis J, Siegfried J, Frigyesi T L, Tissot R

出版信息

J Neural Transm. 1974;35(1):13-22. doi: 10.1007/BF01245332.

DOI:10.1007/BF01245332

PMID:4824675

Abstract

摘要

相似文献

Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.帕金森病与纹状体多巴胺：人脑中存在多巴胺的体内形态学证据

J Neural Transm. 1974;35(1):13-22. doi: 10.1007/BF01245332.

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.脑多巴胺与帕金森综合征和亨廷顿综合征。临床、形态学及神经化学相关性

J Neurol Sci. 1973 Dec;20(4):415-55. doi: 10.1016/0022-510x(73)90175-5.

Parkinson's disease: from brain homogenate to treatment.帕金森病：从脑匀浆到治疗

Fed Proc. 1973 Feb;32(2):183-90.

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.用正电子发射断层扫描测量帕金森病患者的脑多巴胺代谢。

J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):853-60. doi: 10.1136/jnnp.49.8.853.

The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中纹状体多巴胺能神经元的命运。

Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.

[Influencing of Parkinson's syndrome via intervention in the dopamine metabolism].[通过干预多巴胺代谢对帕金森综合征的影响]

Ned Tijdschr Geneeskd. 1973 Feb 24;117(8):296-305.

Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.帕金森病的神经化学：纹状体与边缘系统多巴胺之间的关系

Adv Biochem Psychopharmacol. 1978;19:293-300.

[Striatal dopamine availability in Parkinson's disease--with reference to the wearing-off phenomenon].[帕金森病纹状体多巴胺可用性——与剂末现象的关系]

Rinsho Shinkeigaku. 1984 Oct;24(10):1008-16.

Striatal dopamine distribution in parkinsonian patients during life.帕金森病患者生前纹状体多巴胺分布情况

J Neurol Sci. 1985 Jul;69(3):223-30. doi: 10.1016/0022-510x(85)90135-2.

Alterations in brain opiate receptors in Parkinson's disease.

Brain Res. 1979 Sep 14;173(2):378-82. doi: 10.1016/0006-8993(79)90642-5.

引用本文的文献

Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.左旋多巴与脱羧酶抑制剂：其临床药理学及在帕金森病治疗中的应用综述

Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001.

Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.左旋多巴单独及与外周脱羧酶抑制剂苄丝肼（美多芭）联合用于帕金森病治疗：一项对照临床试验。

J Neurol. 1975 Dec 2;211(1):1-9. doi: 10.1007/BF00312459.

本文引用的文献

[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].[去甲肾上腺素和多巴胺（3-羟酪胺）在人脑内的分布及其在锥体外系疾病中的表现]

Klin Wochenschr. 1960 Dec 15;38:1236-9. doi: 10.1007/BF01485901.

Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.外周脱羧酶抑制后，3,4-二羟基苯丙氨酸引起脑内儿茶酚胺增加。

Nature. 1967 Aug 19;215(5103):852-3. doi: 10.1038/215852b0.

[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].口服左旋多巴联合脱羧酶抑制剂（Ro IV 46.02）治疗帕金森综合征

Presse Med (1893). 1969 Apr 5;77(17):619-22.

[Selective concentration of dopamine in the parenchyma of the rat brain].[大鼠脑实质中多巴胺的选择性富集]

Helv Physiol Pharmacol Acta. 1967;25(4):CR411+.

[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].[左旋多巴联合脱羧酶抑制剂治疗帕金森综合征。II]

Rev Neurol (Paris). 1970 Nov;123(5):297-319.

[Two years experience with L-DOPA in association with a decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂联合应用两年的经验

Rev Neurol (Paris). 1970 Apr;122(4):243-8.

[The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].

Experientia. 1970 Apr 15;26(4):381-3. doi: 10.1007/BF01896900.

[Biopsies during stereotaxic operations in Parkinson's syndrome].

Neurochirurgia (Stuttg). 1967 May;10(3):106-18. doi: 10.1055/s-0028-1095342.

Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.脑外脱羧酶被抑制后，大脑中由各种氨基酸形成单胺的过程。

Biochem Pharmacol. 1971 Jun;20(6):1243-7. doi: 10.1016/0006-2952(71)90354-6.

Cerebral catecholamines after levodopa therapy.左旋多巴治疗后的脑儿茶酚胺

Arch Neurol. 1971 Nov;25(5):461-7. doi: 10.1001/archneur.1971.00490050095008.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验